Filing metadata

Accession number
0001104659-22-042376
Form type
Form 4
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
Apr 04, 2022
Reporting period
Mar 31, 2022
Description
Insider transaction

Explore SEC Filings Hub